Efficacy and safety of oral NEPA versus fosaprepitant combined with palonosetron for preventing highly emetogenic chemotherapy-induced nausea and vomiting in patients with nasopharyngeal carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback